Clinical Trial Update: Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection [Phase 4]

View source ↗

Summary

Phase 4 trial update on intravitreal aflibercept for diabetic macular edema and diabetic retinopathy reports early anatomical, physiological, and clinical chang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Indonesia University | Conditions: Diabetic Macular Edema, Diabetic Retinopathy | Phase 4 | Status: COMPLETED